Mechanical Thrombectomy for Acute Pulmonary Embolism

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions
Acute Pulmonary Embolism
Interventions
PROCEDURE

Innovative Device Group

Catheter-based thrombectomy is performed within 4 hours after baseline CTPA acquisition. Pre-procedural anticoagulation with either low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH) is administered prior to thrombectomy. Post-procedural oral anticoagulation is transitioned to rivaroxaban 20 mg once daily (QD).

DRUG

Standard Pharmacological Therapy Group

Following thrombolytic agent administration, anticoagulation with rivaroxaban is initiated and maintained at 15 mg twice daily (BID) for the initial 3 weeks, then switched to 20 mg once daily (QD) thereafter.

All Listed Sponsors
lead

RenJi Hospital

OTHER